A detailed history of Martin & CO Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Martin & CO Inc holds 9,671 shares of ABT stock, worth $1 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
9,671
Previous 9,852 1.84%
Holding current value
$1 Million
Previous $1.08 Million 1.38%
% of portfolio
0.28%
Previous 0.28%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$109.52 - $120.96 $19,823 - $21,893
-181 Reduced 1.84%
9,671 $1.1 Million
Q4 2023

Feb 13, 2024

SELL
$90.19 - $110.4 $32,648 - $39,964
-362 Reduced 3.54%
9,852 $1.08 Million
Q3 2023

Nov 02, 2023

SELL
$95.53 - $114.62 $3,725 - $4,470
-39 Reduced 0.38%
10,214 $989,000
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $35,776 - $39,862
-355 Reduced 3.35%
10,253 $1.12 Million
Q1 2023

May 09, 2023

SELL
$96.86 - $114.01 $12,688 - $14,935
-131 Reduced 1.22%
10,608 $1.07 Million
Q4 2022

Feb 03, 2023

BUY
$95.06 - $111.52 $27,092 - $31,783
285 Added 2.73%
10,739 $1.18 Million
Q3 2022

Oct 26, 2022

BUY
$96.76 - $112.03 $21,577 - $24,982
223 Added 2.18%
10,454 $1.01 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $16,127 - $19,492
158 Added 1.57%
10,231 $1.11 Million
Q1 2022

May 04, 2022

SELL
$114.02 - $139.04 $64,649 - $78,835
-567 Reduced 5.33%
10,073 $1.19 Million
Q4 2021

Feb 01, 2022

SELL
$115.53 - $141.46 $4,967 - $6,082
-43 Reduced 0.4%
10,640 $1.5 Million
Q3 2021

Nov 02, 2021

BUY
$116.66 - $129.06 $96,244 - $106,474
825 Added 8.37%
10,683 $1.26 Million
Q2 2021

Jul 28, 2021

SELL
$105.79 - $124.53 $68,128 - $80,197
-644 Reduced 6.13%
9,858 $1.14 Million
Q1 2021

May 14, 2021

SELL
$108.84 - $128.23 $1.05 Million - $1.24 Million
-9,643 Reduced 47.87%
10,502 $1.26 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $1,050 - $1,144
10 Added 0.05%
20,145 $2.21 Million
Q3 2020

Nov 12, 2020

SELL
$91.64 - $111.29 $4,582 - $5,564
-50 Reduced 0.25%
20,135 $2.19 Million
Q2 2020

Aug 19, 2020

BUY
$76.57 - $98.0 $10,719 - $13,720
140 Added 0.7%
20,185 $1.85 Million
Q1 2020

May 13, 2020

SELL
$62.82 - $91.86 $628,639 - $919,243
-10,007 Reduced 33.3%
20,045 $1.58 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $392 - $437
5 Added 0.02%
30,052 $2.61 Million
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $11,457 - $12,423
-140 Reduced 0.46%
30,047 $2.51 Million
Q2 2019

Aug 15, 2019

SELL
$72.88 - $85.0 $60,490 - $70,550
-830 Reduced 2.68%
30,187 $2.54 Million
Q1 2019

May 15, 2019

SELL
$66.22 - $80.06 $30,461 - $36,827
-460 Reduced 1.46%
31,017 $2.48 Million
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $4,917 - $5,570
75 Added 0.24%
31,477 $2.28 Million
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $23,715 - $28,610
-390 Reduced 1.23%
31,402 $2.3 Million
Q2 2018

Aug 15, 2018

BUY
$57.57 - $63.54 $54,403 - $60,045
945 Added 3.06%
31,792 $1.94 Million
Q1 2018

May 15, 2018

SELL
$56.27 - $63.62 $1.44 Million - $1.63 Million
-25,543 Reduced 45.3%
30,847 $1.85 Million
Q4 2017

Feb 15, 2018

SELL
$53.68 - $57.47 $1,073 - $1,149
-20 Reduced 0.04%
56,390 $3.22 Million
Q3 2017

Nov 15, 2017

SELL
$48.06 - $53.64 $291,964 - $325,863
-6,075 Reduced 9.72%
56,410 $3.01 Million
Q2 2017

Aug 15, 2017

BUY
N/A
62,485
62,485 $3.04 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Martin & CO Inc Portfolio

Follow Martin & CO Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Martin & CO Inc , based on Form 13F filings with the SEC.

News

Stay updated on Martin & CO Inc with notifications on news.